2023 SUMMIT
Oct 25-27, 2022
Nashville, TN

AN ACTION-ORIENTED SUMMIT ON THE DATA AND DIGITAL INFRASTRUCTURE PRECISION MEDICINE NEEDS TO THRIVE

Stakeholders across the healthcare system face significant barriers to the effective implementation of precision medicine.

Solutions must carefully consider the practical realities of a complex, multi-stakeholder environment.

This Summit provides influential leaders a candid, collaborative forum to define and implement solutions that connect the genetic health information network.

An intimate meeting of influential leaders from across the Genetic Health Information Network

Representing all stakeholders in this ecosystem, including
  • Health plans
  • Clinicians
  • Hospital systems
  • Researchers
  • Policy makers
  • Patients & Advocates
  • Laboratories
  • IT Vendors
  • Pharma

2023 Organizing Committee

PRISCILLA ALFARO, MD

VP, Payment Integrity

Blue Cross and Blue Shield of North Carolina

JIM ALMAS, MD

VP & National Medical Director, Clinical Effectiveness

LabCorp

MARA ASPINALL

Partner

Illumina Ventures

DIANE BAKER, MS, CGC

Special Advisor to the President

Sarah Lawrence College

DAWN BARRY

Co-Founder & President

LunaDNA

TRISH BROWN, MS CGC

Genomics and Precision Medicine Program Director

Aetna

CARLOS BUSTAMANTE, PHD

 Founder & CEO

Galatea Bio, Inc.

PETER DEVAULT

VP, Interoperability & Genomics

Epic

JOHN FOX, MD, MHA

Senior Medical Director for the Americas, Market Access

Illumina

GILLIAN HOOKER, PHD, SCM, CGC

Chief Scientific Officer

Concert Genetics

STEVE KEILES, MS, CGC

Executive Director, Genomic Services, Clinical Solutions

Quest Diagnostics

HOWARD LEVY, MD, PHD

Chief Medical Information Officer

Maryland Primary Care Physicians

VINCENT NELSON, MD

Fmr SVP, Medical Affairs & Deputy CMO

Centene

LORI PRESTESATER

SVP, Health Solutions

American Medical Association (AMA)

BEN SOLOMON, MD

Clinical Director, National Human Genome Research Institute

National Institutes of Health (NIH)

The only multi-stakeholder gathering focused on solving the data, digital infrastructure, and economic challenges facing precision medicine

Intimate, carefully curated, invitation-only gathering

Full spectrum of stakeholders

Focused on needs and solutions

Collaborative, discussion-oriented format

Chatham-house rules — non-attribution

No sponsored talks, sales pitches or marketing lists

Published conference summary and recommendations

Identify and resolve practical barriers facing precision medicine by

  • Improving the capture of clinical effectiveness and economic value data
  • Simplifying the test ordering and resulting workflow for clinicians, hospitals and labs
  • Streamlining the genetic test billing, adjudication and payment process
  • Reducing the frequency of misordered tests and surprise bills for patients
  • Empowering patients to harness the insights in their genetic makeup for greater health

2023 Speakers & Agenda

Click here for working agenda

Nick Seddon

CEO
Optum Genomics

SVP
UnitedHealth Group

Leslie Henshaw

Partner

Deerfield Management

Tom Osborne

Head of Strategy & Partnerships

Verily, an Alphabet company

Dawn Cardeiro, MS

Director, Precision Medicine

Point32Health

Girish Putcha, MD, PhD

Principal

Precision Medicine & Diagnostics, LLC

Dave Stevenson

Managing Director

Merck Global Health Innovation Fund

Neha Kumar, ScM

Global Commercial Strategy – Precision Medicine

Janssen

Mara Aspinall

Partner

Illumina Ventures

Eric Dishman

CEO

DishStrong Innovation, LLC

Jenn Dickey, PhD

Head, Regulatory and Quality, PGDx

LabCorp

Ross Hoffman, MD

Chief Medical Officer, Pharmacy & Innovation

Centene

Alix Lacoste, PhD

AI Computational Biology Director

Invitae

Matt Bettonville

Investor

Yosemite

LENA CHAIHORSKY

Co-Founder & SVP, Payer Innovation

Alva10

Sam Asgarian, MD

Chief Medical Officer

Curve Biosciences

Ryan Taft, PhD

VP, Scientific Research

Illumina Ventures

Kathryn Phillips, PhD

Professor & Director, Center for Translational and Policy Research on Precision Medicine

UCSF

Lee Washington, MD, MPH

Senior Medical Director, National Accounts

Aetna

Sara Riordan, MS, CGC

VP, Strategy

Genome Medical

Mick Correll

President

Genospace

Past Speakers

Titles and organizational affiliations are reflective of the time of the previous Summit and may have since changed.
Francis Collins, MD, PhD

Acting Science Advisor to the President of the United States

Carlos Bustamante, PhD

Founder & CEO

Galatea Bio, Inc.

Trent Haywood, MD, JD

SVP & Chief Medical Officer

Blue Cross Blue Shield Association

Dee Anna Smith

CEO

Sarah Cannon

Rob Metcalf

CEO

Concert Genetics

Lisa Alderson

Founder & CEO

Genome Medical

Ben Solomon, MD

Clinical Director, NHGRI

National Institutes of Health (NIH)

Mira Irons, MD

Chief Health & Science Officer

American Medical Association (AMA)

James Lu, MD, PhD

Co-founder & CEO

Helix

Ellen Matloff, MS, CGC

Co-founder & CEO

MyGeneCounsel

Eli Casdin

Chief Investment Officer

Casdin Capital

Taha Kass-Hout, MD, MS

Chief Health Informatics Officer

FDA

Jill Hagenkord, MD

Chief Medical Officer

Optum Genomics

Phil Febbo, MD

Chief Medical Officer

Illumina

Gillian Hooker, PhD, ScM, CGC

Chief Scientific Officer

Concert Genetics

Bob Nussbaum, MD

Chief Medical Officer

Invitae

Dawn Barry

President & Co-founder

LunaDNA

Kate Donigan, PhD

Director, Personalized Medicine and Molecular Genetics
Deputy Office Director (acting), CDRH/OIR

FDA

Matt Might, PhD

Director, Hugh Kaul Precision Medicine Institute

University of Alabama Birmingham

Shuvayu Sen, PhD

Executive Director, Center for Observational & Real-World Evidence

Merck

Trish Brown, MS, CGC

Genomics and Precision Medicine Program Director

Aetna

Nick Naclerio

Founding Partner

Illumina Ventures

Deven McGraw

Lead, Data Stewardship & Data Sharing

Invitae

Caleb Bupp, MD

Division Chief, Medical Genetics and Genomics

Spectrum Health and Helen DeVos Children’s Hospital

Bryce Olson

Global Marketing Director, Health & Life Sciences

Intel

Mara Aspinall

Managing Director & Co-founder

BlueStone Venture Partners

Lon Castle, MD

Associate CMO, Precision Medicine Services

eviCore

Jessica Zeaske, PhD

Partner

Echo Health Ventures

Vincent Nelson, MD, MPH

SVP & Deputy Chief Medical Officer

Centene

Christy Moore, MS, CGC

Genetics Program Manager

Blue Shield of California

John Fox, MD, MHA

Senior Medical Director, Americas, Market Access

Illumina

Matt Nelson, PhD

VP, Genetics & Genomics

Deerfield Discovery & Development

Suzanne Belinson, PhD

VP, Commercial Markets

Tempus

Priscilla Alfaro, MD

VP, Payment Integrity

Blue Cross Blue Shield of North Carolina

Peter Devault

VP, Genomics & Interoperability

Epic

Steve Goldberg, MD

VP, Chief Health Officer, Medical Affairs & Diagnostic Services

Quest Diagnostics

Ben Park, MD, PhD

Director, Vanderbilt-Ingram Cancer Center
& Professor of Medicine (Hematology/Oncology)

Vanderbilt University Medical Center

Craig Hunter

Vice President & General Manager
Oncology, Genetics, and Laboratory Medicine

Carelon

Holli Dilks, PhD

Global Head of Field Medical, Medical Affairs

Foundation Medicine

Jim Jirjis, MD

VP, Chief Health Information Officer

HCA Healthcare

Howard Levy, MD, PhD

Associate Professor of Medicine

Johns Hopkins Medical Center

Julie Eggington, MS, PhD

Co-founder & CEO

Center for Genomic Interpretation

Dax Kurbegov, MD

VP & Physician-in-Chief of Clinical Programs

Sarah Cannon

Katheryn Lang, MD

Global Medical Strategy Head of Data Science

Pfizer

+78 Net Promoter Score

This Summit is back by popular demand thanks to the enthusiastic response of last year’s participants.

“Intimate engagement with key stakeholders in the genomic medicine space that does not otherwise happen all that often…Excellent and efficient organization and moderation with summary of key points throughout.”

  • Director, Molecular Pathology

“Excellent speakers, panels, participants, and facilitation on relevant topics”

  • CEO, genomics company

“It was a unique and diverse group of stakeholders with (most importantly) time to interact with each other. Key gaps that need to be bridged were openly discussed and at least understood, if not resolved.”

  • Chief Medical Officer

“I thought that the summit raised important issues and brought together interested and diverse individuals to exchange ideas and propose serious solutions to real problems in the field.”

  • President, advocacy organization

“Open discussion, and a focus on actionable takeaways. Attendance by people who are influential.”

  • Director, Science Policy
This event is by invitation only. If you would like to nominate somebody, including yourself, to participate in the summit, please complete the following form: